Canagliflozin (N=23)	Sitagliptin (N=21)	Overall (N=44)	p-value
Gender
Female	10 (43.5%)	9 (42.9%)	19 (43.2%)	0.999
Male	13 (56.5%)	12 (57.1%)	25 (56.8%)
Age (years)
Mean (SD)	60.5 (9.30)	60.0 (10.4)	60.3 (9.73)	0.999
Median [Min, Max]	60.0 [37.0, 74.0]	61.0 [35.0, 74.0]	61.0 [35.0, 74.0]
Smoking
No	17 (73.9%)	15 (71.4%)	32 (72.7%)	0.983
Yes	6 (26.1%)	6 (28.6%)	12 (27.3%)
Drinking
No	17 (73.9%)	16 (76.2%)	33 (75.0%)	0.985
Yes	6 (26.1%)	5 (23.8%)	11 (25.0%)
Diabetic.Complication
No	18 (78.3%)	15 (71.4%)	33 (75.0%)	0.872
Yes	5 (21.7%)	6 (28.6%)	11 (25.0%)
CHD
No	21 (91.3%)	20 (95.2%)	41 (93.2%)	0.875
Yes	2 (8.7%)	1 (4.8%)	3 (6.8%)
Liver.Dysfunction
No	23 (100%)	20 (95.2%)	43 (97.7%)	0.571
Yes	0 (0%)	1 (4.8%)	1 (2.3%)
Hypertension
No	9 (39.1%)	4 (19.0%)	13 (29.5%)	0.345
Yes	14 (60.9%)	17 (81.0%)	31 (70.5%)
Hyperlipidemia
No	4 (17.4%)	6 (28.6%)	10 (22.7%)	0.677
Yes	19 (82.6%)	15 (71.4%)	34 (77.3%)
CKD
No	22 (95.7%)	20 (95.2%)	42 (95.5%)	0.998
Yes	1 (4.3%)	1 (4.8%)	2 (4.5%)
SBP (mmHg)
Mean (SD)	135 (10.1)	136 (15.6)	135 (12.9)	0.834
Median [Min, Max]	134 [121, 164]	139 [103, 162]	136 [103, 164]
DBP (mmHg)
Mean (SD)	83.5 (6.89)	82.7 (10.3)	83.1 (8.57)	0.922
Median [Min, Max]	82.0 [72.0, 94.0]	83.0 [65.0, 103]	82.5 [65.0, 103]
BMI (Kg/m2)
Mean (SD)	25.9 (2.79)	26.7 (2.35)	26.3 (2.59)	0.49
Median [Min, Max]	25.0 [20.3, 31.2]	26.3 [23.2, 31.8]	25.8 [20.3, 31.8]
FBG (mmol/L)
Mean (SD)	8.74 (1.96)	8.16 (1.94)	8.46 (1.95)	0.39
Median [Min, Max]	8.80 [5.20, 12.8]	7.30 [5.70, 12.8]	8.30 [5.20, 12.8]
HbA1c (%)
Mean (SD)	7.88 (0.703)	7.83 (0.853)	7.85 (0.769)	0.783
Median [Min, Max]	7.80 [7.00, 9.30]	7.60 [7.00, 9.90]	7.70 [7.00, 9.90]
Urinary.Protein
negative	14 (60.9%)	17 (81.0%)	31 (70.5%)	0.698
slight	6 (26.1%)	3 (14.3%)	9 (20.5%)
moderate	3 (13.0%)	1 (4.8%)	4 (9.1%)